Magnesium Replacement and Hyperglycemia After Kidney Transplantation
NCT04382157
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hypomagnesemia
Kidney Transplantation
Interventions
DRUG:
Mablet 360 mg
DRUG:
Placebo
Sponsor
Oslo University Hospital